UCB leadership discusses how bridging regulatory approval and real-world access requires integrated care coordination and a long-term commitment to the patient journey.
Kimberly Moran, PhD, MBA
Advertisement
Kimberly Moran, PhD, MBA, is the head of US Rare Disease at UCB.
Articles by Kimberly Moran, PhD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation
2
Colleen Cotton, MD, on the importance of early recognition in hidradenitis suppurativa
3
FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults
4
FDA accepts mavacamten (Camzyos) application for adolescent obstructive hypertrophic cardiomyopathy
5